Cargando…
Multi-modality detection of SARS-CoV-2 in faecal donor samples for transplantation and in asymptomatic emergency surgical admissions
Background: Faecal transplantation is an evidence-based treatment for Clostridioides difficile. Patients infected with SARS-CoV-2 have been shown to shed the virus in stool for up to 33 days, well beyond the average clearance time for upper respiratory tract shedding. We carried out an analytical an...
Autores principales: | Manzoor, Susan E., Zaman, Shafquat, Whalley, Celina, Inglis, David, Bosworth, Andrew, Kidd, Michael, Shabir, Sahida, Quraishi, Nabil, Green, Christopher A., Iqbal, Tariq, Beggs, Andrew D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
F1000 Research Limited
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8311808/ https://www.ncbi.nlm.nih.gov/pubmed/34367617 http://dx.doi.org/10.12688/f1000research.52178.1 |
Ejemplares similares
-
The journey towards safely restarting faecal microbiota transplantation services in the UK during the COVID-19 era
por: Quraishi, Mohammed Nabil, et al.
Publicado: (2021) -
Screening faecal microbiota transplant donors for SARS-CoV-2 by molecular testing of stool is the safest way forward
por: Green, Christopher A, et al.
Publicado: (2020) -
Systematic review of donor and recipient predictive biomarkers of response to faecal microbiota transplantation in patients with ulcerative colitis
por: Rees, Nia Paddison, et al.
Publicado: (2022) -
Meta‐analysis of the demographic and prognostic significance of gastrointestinal symptoms in COVID‐19 patients
por: Zaman, Shafquat, et al.
Publicado: (2022) -
Gaps in knowledge and future directions for the use of faecal microbiota transplant in the treatment of inflammatory bowel disease
por: Yalchin, Mehmet, et al.
Publicado: (2019)